Literature DB >> 28040712

Comment on Hatzoglou et al: Dynamic contrast-enhanced MRI perfusion versus 18FDG PET/CT in differentiating brain tumor progression from radiation injury.

Francesco Cicone1,2, Norbert Galldiks3,4, Giuseppe Minniti5, Christian P Filss3,6, Francesco Scopinaro2, John O Prior1, Nathalie L Albert7, Karl-Josef Langen6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28040712      PMCID： PMC5464086          DOI： 10.1093/neuonc/now283

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  8 in total

Review 1.  Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.

Authors:  Nathalie L Albert; Michael Weller; Bogdana Suchorska; Norbert Galldiks; Riccardo Soffietti; Michelle M Kim; Christian la Fougère; Whitney Pope; Ian Law; Javier Arbizu; Marc C Chamberlain; Michael Vogelbaum; Ben M Ellingson; Joerg C Tonn
Journal:  Neuro Oncol       Date:  2016-04-21       Impact factor: 12.300

2.  Neuro-oncology: Amino acid PET for brain tumours - ready for the clinic?

Authors:  Karl-Josef Langen; Colin Watts
Journal:  Nat Rev Neurol       Date:  2016-06-10       Impact factor: 42.937

3.  Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.

Authors:  Garry Ceccon; Philipp Lohmann; Gabriele Stoffels; Natalie Judov; Christian P Filss; Marion Rapp; Elena Bauer; Christina Hamisch; Maximilian I Ruge; Martin Kocher; Klaus Kuchelmeister; Bernd Sellhaus; Michael Sabel; Gereon R Fink; Nadim J Shah; Karl-Josef Langen; Norbert Galldiks
Journal:  Neuro Oncol       Date:  2017-02-01       Impact factor: 12.300

4.  Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery.

Authors:  Francesco Cicone; Giuseppe Minniti; Andrea Romano; Annalisa Papa; Claudia Scaringi; Francesca Tavanti; Alessandro Bozzao; Riccardo Maurizi Enrici; Francesco Scopinaro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-15       Impact factor: 9.236

5.  Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis.

Authors:  Laura L Horky; Edward M Hsiao; Stephanie E Weiss; Jan Drappatz; Victor H Gerbaudo
Journal:  J Neurooncol       Date:  2010-09-14       Impact factor: 4.130

6.  A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.

Authors:  Vaios Hatzoglou; T Jonathan Yang; Antonio Omuro; Igor Gavrilovic; Gary Ulaner; Jennifer Rubel; Taylor Schneider; Kaitlin M Woo; Zhigang Zhang; Kyung K Peck; Kathryn Beal; Robert J Young
Journal:  Neuro Oncol       Date:  2015-12-19       Impact factor: 12.300

7.  Repeated stereotactic radiosurgery for patients with progressive brain metastases.

Authors:  Giuseppe Minniti; Claudia Scaringi; Sergio Paolini; Enrico Clarke; Francesco Cicone; Vincenzo Esposito; Andrea Romano; Mattia Osti; Riccardo Maurizi Enrici
Journal:  J Neurooncol       Date:  2015-09-14       Impact factor: 4.130

8.  Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy.

Authors:  Yuzo Terakawa; Naohiro Tsuyuguchi; Yoshiyasu Iwai; Kazuhiro Yamanaka; Shigeaki Higashiyama; Toshihiro Takami; Kenji Ohata
Journal:  J Nucl Med       Date:  2008-04-15       Impact factor: 10.057
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.